AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $373,982 | -5.8% | 5,351 | -3.2% | 0.00% | – |
Q2 2023 | $397,170 | +19.4% | 5,527 | +2.5% | 0.00% | – |
Q1 2023 | $332,578 | -21.5% | 5,392 | -1.9% | 0.00% | – |
Q4 2022 | $423,829 | +69.5% | 5,495 | -1.9% | 0.00% | – |
Q3 2022 | $250,000 | -69.3% | 5,600 | -73.7% | 0.00% | -100.0% |
Q2 2022 | $815,000 | -7.3% | 21,287 | +0.2% | 0.00% | 0.0% |
Q1 2022 | $879,000 | +9.6% | 21,252 | -0.0% | 0.00% | 0.0% |
Q4 2021 | $802,000 | +14.1% | 21,253 | -0.2% | 0.00% | 0.0% |
Q3 2021 | $703,000 | -51.0% | 21,295 | +0.2% | 0.00% | 0.0% |
Q2 2021 | $1,435,000 | +19.5% | 21,260 | +0.2% | 0.00% | 0.0% |
Q1 2021 | $1,201,000 | -28.9% | 21,228 | +2.4% | 0.00% | -50.0% |
Q4 2020 | $1,689,000 | +14.3% | 20,733 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,478,000 | -13.3% | 20,733 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,705,000 | +2839.7% | 20,733 | +1973.3% | 0.00% | – |
Q1 2020 | $58,000 | -44.2% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $104,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |